Funding

---

Aug 2026: New NIH R01, 1R01AT013366-01A1  
Feb 2026: New NOA for NIH R21, 1R21DA062756-01A1  
Jan 2026: New NOA for NIH P20, 5P20GM109097-09
July-2025: New funding from the Translational Neuroscience Grant Program. 
​June-2025: INSPIRE Lab's invention selected for OKBioStart Program. 
​March-2025: The lab filed for a provisional patent on a novel treatment strategy for treating obesity.
Nov-2024: Industry funding from Palatin Technologies for examining their drug portfolio.
Aug-2024:  New COBRE PILOT Grant to examine neuroadaptations underlying early life adversity. 
Feb 2023: PhRMA Foundation Early Career Award. 
Feb-2023 -WV CTSI Award to study the role of prenatal opioid insult on neurobehavioral outcomes.



​




​
Epigenetic tinkering with neurotransmitters
Hippocampal plasticity may drive cocaine relapse
Mount Sinai Researchers Discover a Novel Role for Dopamine That Impacts Gene Expression Related to Cocaine Abuse
Dopamine modification on chromatin linked to addiction
A New Approach to Curbing Drug Use Relapse
Secret to Opiate Relapse Discovered: Synaptic Rewiring
How relapse happens: Opiates reduce the brain's ability to form, maintain synapses 
​
​
​
​
​

​


​

---